Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Given Average Rating of "Buy" by Brokerages

Addus HomeCare logo with Medical background

Shares of Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) have received an average rating of "Buy" from the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have issued a strong buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $133.67.

A number of equities analysts have commented on ADUS shares. Citizens Jmp raised shares of Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. StockNews.com upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Wednesday, December 11th. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Finally, KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 price target on the stock.

Read Our Latest Analysis on ADUS

Addus HomeCare Stock Down 0.7 %

ADUS stock traded down $0.93 during mid-day trading on Wednesday, hitting $125.35. The company had a trading volume of 89,089 shares, compared to its average volume of 133,451. The company has a 50-day moving average price of $125.29 and a 200 day moving average price of $125.71. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.12. The company has a market capitalization of $2.27 billion, a price-to-earnings ratio of 28.68, a P/E/G ratio of 2.11 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. During the same period in the prior year, the firm earned $1.03 EPS. The company's revenue for the quarter was up 7.1% on a year-over-year basis. As a group, analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the company's stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently made changes to their positions in the stock. Wasatch Advisors LP increased its position in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after acquiring an additional 110,010 shares during the period. Point72 Asset Management L.P. increased its holdings in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock worth $82,930,000 after purchasing an additional 5,421 shares during the last quarter. State Street Corp lifted its holdings in shares of Addus HomeCare by 4.4% during the third quarter. State Street Corp now owns 663,610 shares of the company's stock worth $88,280,000 after purchasing an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. boosted its position in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after buying an additional 75,409 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines